Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Celecoxib vs Celecoxib + Metformin in FAP
NCT06545526Phase 3Recruiting
- Sponsor
- Yonsei University
- Start
- Aug 2024
- Primary completion
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of liquid metformin (Aspargo Labs) in familial adenomatous polyposis (FAP), sponsored by Yonsei University. Started Aug 2024; status: recruiting.
02
Drugs
liquid metformin (Aspargo Labs)
03
Conditions
familial adenomatous polyposis (FAP)
Beyond the preview
Go deeper on NCT06545526.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06545526.